Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Cash Flow-to-Debt Ratio
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Cash Flow-to-Debt Ratio of 0.13x as of September 2025, meaning its operating cash flow of CN¥486.04 Million could theoretically repay 0% of its total liabilities (CN¥3.63 Billion) in one year. See free cash flow generation of Shanghai Shyndec Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Shyndec Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2004–2024)
Historical debt coverage capacity for Shanghai Shyndec Pharmaceutical Co Ltd across 21 annual periods. Also explore Shanghai Shyndec Pharmaceutical Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2024)
Year-by-year debt coverage analysis for Shanghai Shyndec Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600420 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | CN¥2.26 Billion | CN¥4.63 Billion | ▲ +41.9% |
| 2023 | 0.34x | CN¥1.72 Billion | CN¥5.01 Billion | ▼ -10.2% |
| 2022 | 0.38x | CN¥2.86 Billion | CN¥7.48 Billion | ▲ +97.8% |
| 2021 | 0.19x | CN¥1.68 Billion | CN¥8.70 Billion | ▲ +4.3% |
| 2020 | 0.19x | CN¥1.56 Billion | CN¥8.43 Billion | ▲ +22.9% |
| 2019 | 0.15x | CN¥1.27 Billion | CN¥8.44 Billion | ▼ -27.6% |
| 2018 | 0.21x | CN¥1.67 Billion | CN¥8.02 Billion | ▼ -32.4% |
| 2017 | 0.31x | CN¥2.31 Billion | CN¥7.52 Billion | ▲ +196.3% |
| 2016 | 0.10x | CN¥838.58 Million | CN¥8.08 Billion | ▲ +15.7% |
| 2015 | 0.09x | CN¥226.65 Million | CN¥2.53 Billion | ▼ -16.1% |
| 2014 | 0.11x | CN¥258.51 Million | CN¥2.42 Billion | ▼ -6.2% |
| 2013 | 0.11x | CN¥207.50 Million | CN¥1.82 Billion | ▼ -24.7% |
| 2012 | 0.15x | CN¥193.41 Million | CN¥1.28 Billion | ▼ -39.5% |
| 2011 | 0.25x | CN¥136.12 Million | CN¥544.70 Million | ▼ -35.3% |
| 2010 | 0.39x | CN¥115.11 Million | CN¥298.05 Million | ▼ -15.1% |
| 2009 | 0.45x | CN¥97.43 Million | CN¥214.24 Million | ▲ +28.0% |
| 2008 | 0.36x | CN¥58.04 Million | CN¥163.41 Million | ▼ -48.4% |
| 2007 | 0.69x | CN¥82.31 Million | CN¥119.57 Million | ▼ -19.4% |
| 2006 | 0.85x | CN¥73.60 Million | CN¥86.15 Million | ▲ +57.4% |
| 2005 | 0.54x | CN¥57.90 Million | CN¥106.67 Million | ▲ +137.0% |
| 2004 | 0.23x | CN¥17.02 Million | CN¥74.32 Million | — |